Omnicell: Steady Service Rollout Suggests Moderate Growth Ahead, Justifying Hold Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Omnicell (OMCL), Tandem Diabetes Care (TNDM) and Amgen (AMGN)
Buy Rating on Omnicell Affirmed: Innovation and Growth Outlook Fuel Optimism for FY24 and Beyond
Piper Sandler Keeps Their Buy Rating on Omnicell (OMCL)
Analysts Conflicted on These Healthcare Names: PROCEPT BioRobotics (PRCT), Springworks Therapeutics (SWTX) and Omnicell (OMCL)
Omnicell Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Amgen (AMGN) and Omnicell (OMCL)
Barclays Sticks to Its Sell Rating for Omnicell (OMCL)
Omnicell Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), AnaptysBio (ANAB) and LivaNova (LIVN)
Craig-Hallum Sticks to Its Buy Rating for Omnicell (OMCL)
Omnicell (OMCL) Receives a Buy From Craig-Hallum
Omnicell's Strategic Shift to Recurring Revenue: A Cautious Hold Amidst Transformation Uncertainty
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Glaukos (GKOS) and Omnicell (OMCL)
Omnicell's Steady Demand and Modest Revenue Projections Justify Hold Rating
Omnicell Analyst Ratings
Analysts' Top Healthcare Picks: Merck & Company (MRK), Omnicell (OMCL)
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Replimune Group (REPL) and Phibro Animal Health (PAHC)
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Edwards Lifesciences (EW) and Omnicell (OMCL)
Wells Fargo Reaffirms Their Hold Rating on Omnicell (OMCL)
No Data